Lujin Wu
Impact in
- Biochemistry top 2%
- Eicosanoids and Hypertension Pharmacology
-
- Cardiac Fibrosis and Remodeling
- Cardiovascular Function and Risk Factors
Papers in
-
- Eicosanoids and Hypertension Pharmacology 4
-
- Cardiac Fibrosis and Remodeling 3
- Cardiovascular Function and Risk Factors 2
- Co-authors
- Dao Wen Wang (14 shared papers)Wen Zheng (5 shared papers)Lingli Dong (2 shared papers)Jiong Hu (1 shared paper)Ingrid Fleming (1 shared paper)Jing Chen (1 shared paper)Bei Guo Wang (1 shared paper)Chen Chen (4 shared papers)
- Journals
- Journal of Cellular Physiology (2 papers)Frontiers in Pharmacology (2 papers)Frontiers in Cardiovascular Medicine (2 papers)BMC Cancer (1 paper)Hypertension (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Lujin Wu
18 papers receiving 1.8k citations
Lujin Wu's Hit Papers
Peers
Comparison fields: 5 of 105
- Biochemistry 168
- Cardiology and Cardiovascular Medicine 239
- Complementary and alternative medicine 92
- Nutrition and Dietetics 119
- Pharmacology 132
Countries citing papers authored by Lujin Wu
This map shows the geographic impact of Lujin Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lujin Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lujin Wu more than expected).
Fields of papers citing papers by Lujin Wu
This network shows the impact of papers produced by Lujin Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lujin Wu. The network helps show where Lujin Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Lujin Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets Hit paper breakdown → | 2021 | 1023 |
| 2 | 2017 | 284 | |
| 3 | 2018 | 87 | |
| 4 | 2015 | 78 | |
| 5 | 2018 | 55 | |
| 6 | 2021 | 39 | |
| 7 | 2017 | 37 | |
| 8 | 2017 | 32 | |
| 9 | 2021 | 27 | |
| 10 | 2019 | 20 | |
| 11 | 2017 | 19 | |
| 12 | 2020 | 18 | |
| 13 | 2022 | 17 | |
| 14 | 2020 | 16 | |
| 15 | 2021 | 9 | |
| 16 | 2020 | 7 | |
| 17 | 2018 | 4 | |
| 18 | 2023 | 1 |
About Lujin Wu
Lujin Wu is a scholar working on Biochemistry, Cardiology and Cardiovascular Medicine, Cancer Research, Epidemiology and Molecular Biology, having authored 18 papers that have together received 1.8k indexed citations. Recurring topics across this work include Eicosanoids and Hypertension Pharmacology (4 papers), Cardiac Fibrosis and Remodeling (3 papers), Peroxisome Proliferator-Activated Receptors (2 papers), Cardiovascular Function and Risk Factors (2 papers), Adipokines, Inflammation, and Metabolic Diseases (2 papers), Inflammatory mediators and NSAID effects (1 paper), COVID-19 Clinical Research Studies (1 paper) and Inflammasome and immune disorders (1 paper). The work is most often cited by research in Biochemistry (168 citations), Cardiology and Cardiovascular Medicine (239 citations), Complementary and alternative medicine (92 citations), Nutrition and Dietetics (119 citations) and Pharmacology (132 citations). Lujin Wu has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Dao Wen Wang, Wen Zheng, Lingli Dong, Jiong Hu, Ingrid Fleming, Jing Chen, Bei Guo Wang, Chen Chen, Jiali Nie and Bei Wang. Their work appears in journals such as Journal of Cellular Physiology, Frontiers in Pharmacology, Frontiers in Cardiovascular Medicine, BMC Cancer and Hypertension.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.